MBIO · Company research

Mustang Bio, Inc. (MBIO): Stock News & Events

Recent company-linked news records available in the database.

RESEARCH CONTEXT

Understand the numbers

Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.

15records availableHealthcare

Stock News & Events data

Database-backed records only

15 rows
titlesummaryurlsourcepublished atsentimentsentiment scorerelevance score
MBIO stock sits near its 52-week low as Nasdaq deadline nears - AD HOC NEWSMBIO stock sits near its 52-week low as Nasdaq deadline nears AD HOC NEWSView source ↗AD HOC NEWSOct 7, 2026neutral00.6
MBIO stock falls 1.91 percent as Q2 loss widens - AD HOC NEWSMBIO stock falls 1.91 percent as Q2 loss widens AD HOC NEWSView source ↗AD HOC NEWSOct 5, 2026neutral00.6
MBIO Q4 2024 Earnings: Wider-Than-Expected Loss Per Share Dominates the Quarter - Revenue Warning Signal - https://www.dars.gov.et/MBIO Q4 2024 Earnings: Wider-Than-Expected Loss Per Share Dominates the Quarter - Revenue Warning Signal https://www.dars.gov.et/View source ↗https://www.dars.gov.et/Oct 1, 2026neutral00.6
Mustang Bio Inc. (MBIO) Shareholding Pattern – Promoters, FIIs & DIIs - Value ResearchMustang Bio Inc. (MBIO) Shareholding Pattern – Promoters, FIIs & DIIs Value ResearchView source ↗Value ResearchSep 2, 2026neutral00.6
Mustang Bio Inc. (MBIO) Q4 2024 Earnings: Wider-than-Expected Loss Amid Pre-Revenue Stage - Post-Earnings Reaction - dars.gov.etMustang Bio Inc. (MBIO) Q4 2024 Earnings: Wider-than-Expected Loss Amid Pre-Revenue Stage - Post-Earnings Reaction dars.gov.etView source ↗dars.gov.etMay 29, 2026neutral00.6
MindBio Announces Stock Consolidation - TheNewswireMindBio Announces Stock Consolidation TheNewswireView source ↗TheNewswireNov 3, 2025neutral00.6
MBIO Stock Earnings: Mustang Bio Beats EPS for Q2 2024 - InvestorPlaceMBIO Stock Earnings: Mustang Bio Beats EPS for Q2 2024 InvestorPlaceView source ↗InvestorPlaceAug 13, 2024neutral00.6
Mustang Bio’s CAR-T MB-106 Achieves Responses in 9 of 10 Patients With Waldenstrom Macroglobulinemia - CGTLive®Mustang Bio’s CAR-T MB-106 Achieves Responses in 9 of 10 Patients With Waldenstrom Macroglobulinemia CGTLive®View source ↗CGTLive®Jun 18, 2024neutral00.6
symbol__ Stock Quote Price and Forecast - CNNsymbol__ Stock Quote Price and Forecast CNNView source ↗CNNJan 18, 2024neutral00.6
The streptococcal phase-variable type I restriction modification system SsuCC20p dictates the methylome of Streptococcus suis impacting the transcriptome and virulence in a zebrafish larvae infection model - ASM JournalsThe streptococcal phase-variable type I restriction modification system SsuCC20p dictates the methylome of Streptococcus suis impacting the transcriptome and virulence in a zebrafish larvae infection model ASM JournalsView source ↗ASM JournalsDec 8, 2023neutral00.6
MindBio Therapeutics Corp. (MBIO.CN) Stock Price, News, Quote & History - Yahoo! Finance CanadaMindBio Therapeutics Corp. (MBIO.CN) Stock Price, News, Quote & History Yahoo! Finance CanadaView source ↗Yahoo! Finance CanadaJun 14, 2023neutral00.6
MBIO Stock Price and Chart — CSE:MBIO - TradingViewMBIO Stock Price and Chart — CSE:MBIO TradingViewView source ↗TradingViewMay 7, 2023neutral00.6
MBIO | Mustang Bio Inc. Stock Overview (U.S.: Nasdaq) - Barron'sMBIO | Mustang Bio Inc. Stock Overview (U.S.: Nasdaq) Barron'sView source ↗Barron'sJul 30, 2021neutral00.6
Mustang Bio Stock Price Forecast. Should You Buy MBIO? - StockInvest.usMustang Bio Stock Price Forecast. Should You Buy MBIO? StockInvest.usView source ↗StockInvest.usDec 1, 2020neutral00.6
Mustang Bio, Inc. (MBIO) Stock Price, News, Quote & History - Yahoo! Finance CanadaMustang Bio, Inc. (MBIO) Stock Price, News, Quote & History Yahoo! Finance CanadaView source ↗Yahoo! Finance CanadaSep 9, 2017neutral00.6

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.